BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1602836)

  • 1. Regulation of SRC-family protein tyrosine kinases by interleukins, IL-2, and IL-3.
    Torigoe T; O-Connor R; Fagard R; Fischer S; Santoli D; Reed JC
    Leukemia; 1992; 6 Suppl 3():94S-97S. PubMed ID: 1602836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-3 regulates the activity of the LYN protein-tyrosine kinase in myeloid-committed leukemic cell lines.
    Torigoe T; O'Connor R; Santoli D; Reed JC
    Blood; 1992 Aug; 80(3):617-24. PubMed ID: 1638019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene transfer investigations of p56-LCK function in IL-2-dependent T-cell lines: implications for mechanisms of IL-2-signal transduction.
    Taichman RS; Torigoe T; Tanaka S; Miyashita T; Reed JC
    Cytokine; 1992 Nov; 4(6):441-53. PubMed ID: 1292628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.
    Susa M; Rohner D; Bichsel S
    Biochem Biophys Res Commun; 1996 Mar; 220(3):729-34. PubMed ID: 8607833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficient expression of p56(lck) in Th2 cells leads to partial TCR signaling and a dysregulation in lymphokine mRNA levels.
    al-Ramadi BK; Nakamura T; Leitenberg D; Bothwell AL
    J Immunol; 1996 Dec; 157(11):4751-61. PubMed ID: 8943376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of src-related tyrosine kinases by IL-3.
    Anderson SM; Jorgensen B
    J Immunol; 1995 Aug; 155(4):1660-70. PubMed ID: 7636226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-I-infected human T cells.
    Mills GB; Arima N; May C; Hill M; Schmandt R; Li J; Miyamoto NG; Greene WC
    Int Immunol; 1992 Nov; 4(11):1233-43. PubMed ID: 1472476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional coupling of the src-family protein tyrosine kinases p59fyn and p53/56lyn with the interleukin 2 receptor: implications for redundancy and pleiotropism in cytokine signal transduction.
    Kobayashi N; Kono T; Hatakeyama M; Minami Y; Miyazaki T; Perlmutter RM; Taniguchi T
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4201-5. PubMed ID: 8483935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 4 inhibits IL-2-induced proliferation of a human T-leukemia cell line without interfering with p56-LCK kinase activation.
    Torigoe T; O'Connor R; Fagard R; Fischer S; Santoli D; Reed JC
    Cytokine; 1992 Sep; 4(5):369-76. PubMed ID: 1420998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of src-like protooncogenes in lymphocyte proliferation.
    Yamamoto T; Yamanashi Y; Takeuchi M; Fusaki N; Uchiumi F; Katagiri T; Semba K; Toyoshima K
    Princess Takamatsu Symp; 1991; 22():293-305. PubMed ID: 1668889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal transduction of interleukin-6 involves tyrosine phosphorylation of multiple cytosolic proteins and activation of Src-family kinases Fyn, Hck, and Lyn in multiple myeloma cell lines.
    Hallek M; Neumann C; Schäffer M; Danhauser-Riedl S; von Bubnoff N; de Vos G; Druker BJ; Yasukawa K; Griffin JD; Emmerich B
    Exp Hematol; 1997 Dec; 25(13):1367-77. PubMed ID: 9406996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 2 regulates the activity of the lyn protein-tyrosine kinase in a B-cell line.
    Torigoe T; Saragovi HU; Reed JC
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2674-8. PubMed ID: 1557373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic changes induced by interleukin-2 (IL-2) and IL-3 in an immature T-lymphocytic leukemia are associated with regulated expression of IL-2 receptor beta chain and of protein tyrosine kinases LCK and LYN.
    O'Connor R; Torigoe T; Reed JC; Santoli D
    Blood; 1992 Aug; 80(4):1017-25. PubMed ID: 1379847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signalling by the p60c-src family of protein-tyrosine kinases.
    Kefalas P; Brown TR; Brickell PM
    Int J Biochem Cell Biol; 1995 Jun; 27(6):551-63. PubMed ID: 7545532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein tyrosine kinase activity in T lymphocytes from patients with systemic lupus erythematosus.
    Blasini AM; Brundula V; Paris M; Rivas L; Salazar S; Stekman IL; Rodriguez MA
    J Autoimmun; 1998 Oct; 11(5):387-93. PubMed ID: 9802921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dual participation of ZAP-70 and scr protein tyrosine kinases is required for TCR-induced tyrosine phosphorylation of Sam68 in Jurkat T cells.
    Lang V; Mège D; Semichon M; Gary-Gouy H; Bismuth G
    Eur J Immunol; 1997 Dec; 27(12):3360-7. PubMed ID: 9464824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lck associates with and is activated by Kit in a small cell lung cancer cell line: inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1.
    Krystal GW; DeBerry CS; Linnekin D; Litz J
    Cancer Res; 1998 Oct; 58(20):4660-6. PubMed ID: 9788619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2 and IL-4 mediate through two distinct kinase pathways for the activation of alphaCD3-induced activated killer cells.
    Wang J; Hargrove ME; Ting CC
    Cell Immunol; 1996 Dec; 174(2):138-46. PubMed ID: 8954613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of the T-cell antigen receptor-CD3 complex signaling pathway by the tyrosine phosphatase inhibitor pervanadate is mediated by inhibition of CD45: evidence for two interconnected Lck/Fyn- or zap-70-dependent signaling pathways.
    Imbert V; Farahifar D; Auberger P; Mary D; Rossi B; Peyron JF
    J Inflamm; 1996; 46(2):65-77. PubMed ID: 8734787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase receptor-dependent and -independent p56/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence.
    Chiaradonna F; Fontana L; Iavarone C; Carriero MV; Scholz G; Barone MV; Stoppelli MP
    EMBO J; 1999 Jun; 18(11):3013-23. PubMed ID: 10357814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.